menuclose
Home • Specialist • Dr Ronen Gurvitch

Accredited TAVI Practitioner in VIC

BOOKING ENQUIRY

Biography


Dr. Ronen Gurvitch completed his medical training at the University of Melbourne followed by specialist cardiology and interventional training at the Royal Melbourne Hospital. After winning the inaugural CSANZ traveling fellowship award he spent two years training in Vancouver Canada with Professor J Read More...

Procedures & Conditions

Procedures Performed
  • Coronary Angiography
  • Coronary Angioplasty and Stenting
  • Intravascular Ultrasound Imaging
  • Fractional Flow Reserve and Pressure Wire
  • Left and Right Heart Catherisation
  • Percutaneous Closure of PFO and ASD
  • Transcatheter Valve Replacement (TAVI/R)
  • Percutaneous Structural Heart Intervention
Conditions Treated
  • Aortic Stenosis
  • Coronary Artery Disease
  • Ischaemic Heart Disease
  • Myocardial Infarction
  • Angina Pectoris

Experience

  • Interventional Cardiologist
    Royal Melbourne Hospital 2011
  • Interventional Cardiology Fellow
    St. Paul’s Hospital, Vancouver, Canada 2009 – 2011
  • Interventional Cardiology Fellow
    Royal Melbourne Hospital 2007 - 2009
  • Advanced Trainee in Cardiology
    Royal Melbourne Hospital 2005 - 2007

Awards

Research & Publications

Publications

1. Anatomical and Procedural Features Associated with Aortic Root Rupture During Balloon-Expandable TRanscatheter Aortic Valve Replacement. Barbanti M, Yang T, Rodès Cabau J, Tamburino C, Wood DA, Jilaihawi H, Blanke P, Makkar R, Latib A, Colombo A, Tarantini G, Raju R, Binder RK, Nguyen G, Freeman M, Kapadia S, Min J, Feuchtner G, Gurtvich R, Hansson N, Pache G, Canovas SJ, Zhang H, Leon MB, Webb JG, Leipsic J. Circulation. 2013;128:244-253

2. Percutaneous closure of a giant saphenous vein graft aneurysm with an amplatzer vascular plug. Brooks MJ, Grigg L, Mitchell P, Iyer R, Zentner D, Gurvitch R. JACC Cardiovasc Interv. 2013 Apr;6(4)

3. Computed tomography-based sizing recommendations for transcatheter aortic valve replacement with balloon-expandable valves: Comparison with transesophageal echocardiography and rationale for implementation in a prospective trial. Willson AB, Webb JG, Freeman M, Wood DA, Gurvitch R, Thompson CR, Moss RR, Toggweiler S, Binder RK, Munt B, Cheung A, Hague C, Ye J, Leipsic JA. J Cardiovasc Comput Tomogr. 2012 Nov-Dec;6(6)

4. Long-term outcomes after transcatheter aortic valve implantation: insights on prognostic factors and valve durability from the Canadian multicenter experience. Rodés-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Osten M, Feindel CM, Natarajan MK, Velianou JL, Martucci G, DeVarennes B, Chisholm R, Peterson M, Thompson CR, Wood D, Toggweiler S, Gurvitch R, Lichtenstein SV, Doyle D, DeLarochellière R, Teoh K, Chu V, Bainey K, Lachapelle K, Cheema A, Latter D, Dumesnil JG, Pibarot P, Horlick E. J Am Coll Cardiol. 2012 Nov 6;60(19)

5. Pathology of transcatheter valve therapy. Nietlispach F, Webb JG, Ye J, Cheung A, Lichtenstein SV, Carere RG, Gurvitch R, Thompson CR, Ostry AJ, Matzke L, Allard MF. JACC Cardiovasc Interv. 2012 May;5(5):582-90.

6. Transcatheter valve-in-valve implantation for failed balloon-expandable transcatheter aortic valves. Toggweiler S, Wood DA, Rodés-Cabau J, Kapadia S, Willson AB, Ye J, Cheung A, Leipsic J, Binder RK, Gurvitch R, Freeman M, Thompson CR, Svensson LG, Dumont E, Tuzcu EM, Webb JG. JACC Cardiovasc Interv. 2012 May;5(5):571-7.

7. Need for permanent pacemaker as a complication of transcatheter aortic valve implantation and surgical aortic valve replacement in elderly patients with severe aortic stenosis and similar baseline electrocardiographic findings. Bagur R, Rodés-Cabau J, Gurvitch R, Dumont É, Velianou JL, Manazzoni J, Toggweiler S, Cheung A, Ye J, Natarajan MK, Bainey KR, DeLarochellière R, Doyle D, Pibarot P, Voisine P, Côté M, Philippon F, Webb JG. JACC Cardiovasc Interv. 2012 May;5(5):540-51.

8. Structural integrity of balloon-expandable stents after transcatheter aortic valve replacement: assessment by multidetector computed tomography. Willson AB, Webb JG, Gurvitch R, Wood DA, Toggweiler S, Binder R, Freeman M, Madden M, Hague C, Leipsic J. JACC Cardiovasc Interv. 2012 May;5(5):525-32.

9. Transcatheter aortic valve replacement: outcomes of patients with moderate or severe mitral regurgitation. Toggweiler S, Boone RH, Rodés-Cabau J, Humphries KH, Lee M, Nombela-Franco L, Bagur R, Willson AB, Binder RK, Gurvitch R, Grewal J, Moss R, Munt B, Thompson CR, Freeman M, Ye J, Cheung A, Dumont E, Wood DA, Webb JG. J Am Coll Cardiol. 2012 Jun 5;59(23):2068-74.

10. Prediction of optimal deployment projection for transcatheter aortic valve replacement: angiographic 3-dimensional reconstruction of the aortic root versus multidetector computed tomography. Binder RK, Leipsic J, Wood D, Moore T, Toggweiler S, Willson A, Gurvitch R, Freeman M, Webb JG. Circ Cardiovasc Interv. 2012 Apr;5(2):247-52. Epub 2012 Mar 20.

11. 3-dimensional aortic annular assessment by multidetector computed tomography predicts moderate or severe paravalvular regurgitation after transcatheter aortic valve replacement: a multicenter retrospective analysis. Willson AB, Webb JG, Labounty TM, Achenbach S, Moss R, Wheeler M, Thompson C, Min JK, Gurvitch R, Norgaard BL, Hague CJ, Toggweiler S, Binder R, Freeman M, Poulter R, Poulsen S, Wood DA, Leipsic J. J Am Coll Cardiol. 2012 Apr 3;59(14):1287-94. Epub 2012 Feb 22.

12. MDCT to guide transcatheter aortic valve replacement and mitral valve repair. Leipsic J, Hague CJ, Gurvitch R, Ajlan AM, Labounty TM, Min JK. Cardiol Clin. 2012 Feb;30(1):147-60

13. Percutaneous aortic valve replacement: vascular outcomes with a fully percutaneous procedure. Toggweiler S, Gurvitch R, Leipsic J, Wood DA, Willson AB, Binder RK, Cheung A, Ye J, Webb JG. J Am Coll Cardiol. 2012 Jan 10;59(2):113-8.

14. A high-risk period for cerebrovascular events exists after transcatheter aortic valve implantation. Tay EL, Gurvitch R, Wijesinghe N, Nietlispach F, Wood D, Cheung A, Ye J, Lichtenstein SV, Carere R, Thompson C, Webb JG. JACC Cardiovasc Interv. 2011 Dec;4(12):1290-7.

15. Impact of periprocedural atrial fibrillation on short-term clinical outcomes following percutaneous coronary intervention. Chan W, Ajani AE, Clark DJ, Stub D, Andrianopoulos N, Brennan AL, New G, Sebastian M, Johnston R, Walton A, Reid CM, Dart AM, Duffy SJ; Melbourne Interventional Group Investigators. Am J Cardiol. 2012 Feb 15;109(4):471-7. Epub 2011 Dec 15.

16. Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention. Chan W, Stub D, Clark DJ, Ajani AE, Andrianopoulos N, Brennan AL, New G, Black A, Shaw JA, Reid CM, Dart AM, Duffy SJ; Melbourne Interventional Group Investigators. Am J Cardiol. 2012 Feb 15;109(4):478-85. Epub 2011 Dec 15.

17. Aortic annulus diameter determination by multidetector computed tomography: reproducibility, applicability, and implications for transcatheter aortic valve implantation. Gurvitch R, Webb JG, Yuan R, Johnson M, Hague C, Willson AB, Toggweiler S, Wood DA, Ye J, Moss R, Thompson CR, Achenbach S, Min JK, Labounty TM, Cury R, Leipsic J. JACC Cardiovasc Interv. 2011 Nov;4(11):1235-45.

18. Transcatheter valve-in-valve implantation for failed surgical bioprosthetic valves. Gurvitch R, Cheung A, Ye J, Wood DA, Willson AB, Toggweiler S, Binder R, Webb JG. J Am Coll Cardiol. State Of The Art. 2011 Nov 15;58(21):2196-209.

19. Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients. Gurvitch R, Tay EL, Wijesinghe N, Ye J, Nietlispach F, Wood DA, Lichtenstein S, Cheung A, Webb JG. Catheter Cardiovasc Interv. 2011 Dec 1;78(7):977-84

20. Valve thrombosis after transcatheter heart valve implantation. Tay EL, Gurvitch R, Wijeysinghe N, Nietlispach F, Wood D, Allard M, Munt B, Cheung A, Webb JG. EuroIntervention. 2011 May;7(1):170-1.

21. Outcomes and Complications of Transcatheter Aortic Valve Implantation Using a Balloon Expandable Valve According to the Valve Academic Research Consortium (VARC) Guidelines. Gurvitch R, Toggweiler S, Willson A, Wijesinghe N, Cheung A, DA Wood, Ye J, Webb JG. EuroIntervention. 2011 May;7(1)

22. MultiDetector Computed Tomography in Transcatheter Aortic Valve Implantation: How We Do It. Leipsic J, Gurvitch R, Achenbach S, Wood DA, Webb JG, Min J. JACC Cardiovasc Interv. 2011 Feb;4(2):228-34.

23. Outcome of patients following transcatheter aortic valve embolization Tay E, Gurvitch R, Wijesinghe N, Nietlispach F, Leipsic J, Wood DA, Yong G, Cheung A, Ye J, Lichtenstein SV, Carere R, Thompson C, Webb JG. JACC Cardiovasc Interv. 2011 Feb;4(2):228-34.

24. Coronary Obstruction Following Transcatheter Aortic Valve-in-Valve Implantation For Failed Surgical Bioprostheses. Gurvitch R, Cheung A, Bedogni F, Webb JG. Catheterization and Cardiovascular Interventions, E pub Jan 4 th 2011, DOI: 10.1002/ccd.22861

25. Transcatheter Transapical Mitral Valve-in-Valve Implantations for Failed Bioprostheses. Cheung A, Gurvitch R, Ye J, Wood DA, Lichtenstein SV, Thompson CR and Webb JG. Journal of Thoracic and Cardiovascular Surgery, 2011 Mar;141(3):711-5.

26.Transcatheter aortic valve implantation: durability of clinical and hemodynamic outcomes beyond 3-years in a large patient cohort. Gurvitch R, Wood DA, Tay E, Leipsic J, Ye J, Lichtenstein SV, Thompson CR, Carere RG, Wijesinghe N, Nietlispach F, Boone RH, Lauck S, Cheung A, Webb JG. Circulation, 2010 Sep 28;122(13):1319-27.

27. Cerebral Embolism Following Transcatheter Aortic Valve Implantation: Comparison of Transfemoral and Transapical Approaches Rodés-Cabau J, Dumont E, Boone R, Larose E, Bagur R, Gurvitch R, Bédard F, Doyle D, Delarochellière R, Jayasuria C, Villeneuve J, Bertrand O, Marrero A, Côté M, Pibarot P, Webb JG. J Am Coll Cardiol, 2011; 57:18-28.

28. An Embolic Deflection Device for Aortic Valve Interventions. Nietlispach F, Wijesinghe N, Gurvitch R, Tay E, Carpenter JP, Burns C, Wood DA, Webb JG. JACC Cardiovascular Interventions, 2010 Nov;3(11):1133-1138.

29. Multislice Computed Tomography for Prediction of Optimal Angiographic Deployment Projections During Transcatheter Aortic Valve Implantation. Gurvitch R, Wood DA, Leipsic J, Tay E, Johnson M, Ye J, Nietlispach F, Wijesinghe N, Cheung A, Webb JG. JACC Cardiovascular Interventions, 2010 Nov;3(11):1157-1165.

30. Comparison between Surgical and Transcatheter Prosthetic Valve Implantation in Patients with Severe Aortic Stenosis and Reduced Left Ventricular Ejection Fraction MA Clavel, JG Webb, J Rodés-Cabau, JB Masson, E Dumont, R De Larochellière, D Doyle, S Bergeron, H Baumgartner, IG Burwash, JG Dumesnil, G Mundigler, R Moss, A Kempny, R Bagur, J Bergler-Klein, Gurvitch R, P Pibarot, Circulation, 2010 Nov 9;122(19):1928-36.

View More

Presentations

1. Cardiac Society of Australia and New Zealand 2013. Comparison of Radiation Doses Between Coronary CT and Conventional Coronary Angiography. Poster Presentation. K. Leong, P. Einsiedel, E. Lui, N. Better, S. Heinze, C. Neal, F. Langenberg, R. Gurvitch, D. Eccleston, S. Joshi

2. American College of Cardiology 2013. Predictors of aortic root injury during balloon–expandable transcatheter aortic valve implantation. Oral Presentation. Marco Barbanti, Tae–Hyun Yang, John Webb, Corrado Tamburino, Hasan Jilaihawi, Raj Makkar, Susheel Kodali, Azeem Latib, Antonio Colombo, Giuseppe Tarantini, Rekha Raju, Ronald Binder, Giang Nguyen, Melanie Freeman, Josep Rodes Cabau, Samir Kapadia, James Min, Gudrun Feuchtner, Ronen Gurvitch, Faisal Alqoofi, Marc Pelletier, Massimo Napodano, David Wood, Martin Leon, Jonathon Leipsic.

3. Transcatheter Valve Therapeutics 2012. The Vancouver Computed Tomography Sizing Guidelines for Transcatheter Aortic Valve Replacement with Balloon Expandable Valves. Oral Presentation. Alex Willson, Webb John, Melanie Freeman, David Wood, Ronen Gurvitch, Chris Thompson, Robert Moss, Stefan Toggweiler, Ronald Binder, Brad Munt, Anson Cheung, Cameron Hague, Jian Ye, Jonathon Leipsic.

4. American College of Cardiology 2012. Three-Dimensional Aortic Annular Assessment By Multidetector Computed Tomography Predicts Moderate Or Severe Paravalvular Regurgitation After Transcatheter Aortic Valve Replacement: A Multicenter Retrospective Analysis. Oral Presentation. A. Willson; J. Webb; T. LaBounty; S. Achenbach; R. Moss; M.Wheeler; C. Thompson; J. Min; R. Gurvitch; B. Norgard; S. Toggweiler; R. K. Binder; C. Hague; M. Freeman; S. Poulter; R. Poulter; D. Wood; L. Jonathon.

5. Comparison Of Mdct Measurements Of Aortic Annulus Size In Systole And Diastole: A Multicenter Evaluation. Oral Presentation. J. Leipsic, A. Willson, S. Achenbach, J. Min, T. LaBounty, R. Gurvitch, S. Toggweiler, R. Binder, R. Moss, R. Cury, C. Thompson, R. Poulter, D. Wood, J. Webb.

6. 3-Dimensional Aortic Annular Assessment by Multidetector Computed Tomography Predicts Moderate or Severe Paravalvular Regurgitation After Transcatheter Aortic Valve Replacement: A Multicenter Retrospective Analysis. A. Willson, J. Webb, MD, T LaBounty, S. Achenbach, R. Moss, M.Wheeler, C.Thompson, J. Min, R. Gurvitch, B. Norgaard, S. Toggweiler, R. Binder, M. Freeman, R. Poulter, S. Poulsen, D.Wood, MD, J. Leipsic.

7. Cardiac Society Australia and New Zealand 2012. Valve Sizing in Transcatheter Aortic Valve Implantation: By How Much is it Safe to Oversize The Short Axis as Determined by Computed Tomography? Oral Presentation. R. Gurvitch, A. Willson, J. Leipsic, M. Watts, M. Brooks, R. Warren, S. Joshi, J. Wong, J. Webb.

8. Sizing Transcatheter Aortic Valves: Can an Ellipse Formula Obviate the Need to Directly Measure the Aortic Annulus Area Using Computed Tomography? Oral Presentation. M. Watts, S. Joshi, J. Wong, E. Liu, R. Warren, M. Larobina, J. Goldblatt, R. Gurvitch

9. Sizing Transcatheter Aortic Valves: Is Sizing According to the Aortic Annular Area Different to Sizing According to the Annular Diameter? Oral Presentation. M. Watts, S. Joshi, J. Wong, E. Liu, R. Warren, M. Larobina, J. Golblatt, R. Gurvitch.

10. The Impact of the Cardiac Cycle on Aortic Annular Dimensions as Measured by Computed Tomography (CT) and the Implications for CT Sizing Criteria in Transcatheter Aortic Valve Replacement. Oral Presentation. Willson, J. Webb, R. Gurvitch, M. Freeman, S. Toggweiler, R. Binder, D. Wood, J. Leipsic

11. The Implications of CT Sizing on Valve Selection and Paravalvular Regurgitation in Transcatheter Aortic Valve Replacement. Oral Presentation. A. Willson, J. Webb, M. Freeman, R. Gurvitch, S. Toggweiler, R. Binder, D. Wood, J. Leipsic.

12. American Heart Association, Chicago, November 2010. Determinants and Outcome of Valvular Dysfunction Following Transcatheter Aortic Valve Implantation. Oral Presentation Jilaihawi H, Webb JG, Gurvitch R, Ye J, Cheung A; Chin D, Spyt T, Kovac J.

13. Transcatheter Therapeutics, Washington, DC, September 2010. Transcathteter Aortic Valve Implantation: Lessons from the learning curve of the first 270 High Risk Patients. Moderated Poster. Gurvitch R, Tay E, Wijesinghe N, Ye J, Nietlispach F, Wood D, Cheung A, Webb JG.

14. Cardiac Society of Australia and New Zealand, Adelaide, August 2010. Transcatheter Aortic Valve Implantation: Long Term Outcomes. Oral Presentation. Gurvitch R, Wood DA, Tay EL, Leipsic J, Ye J, Lichtenstein SV, Thompson CR, Carere RG, Wijesinghe N, Nietlispach F, Boone RH, Lauck S, Cheung A, Webb JG. Heart, Lung and Circulation 2010 (Vol. 19Supplement 2, Page S156)

15. Multislice Computed Tomography for Predition of Optimal Angiographic Deployment Projections During Transcatheter Aortic Valve Implantation. Oral Presentation. Gurvitch R, Wood DA, Leipsic J, Tay E, Johnson M, Ye J, NietlispachF, Wijesinghe N, Cheung A, Webb JG. Heart, Lung and Circulation 2010 (Vol. 19Supplement 2, Page S203)

16. Transcatheter Valve-in-Valve Implantation for Failed Surgical Bioprosthetic Heart Valves. Mini oral presentation. R. Gurvitch, D. Wood, J. Ye, E. Tay, R. Carere, N. Wijesinghe, F. Nietlispach, M. Johnson, R. Moss, J. Leipsic, S. Lichtenstein, A. Cheung, J. Webb. Heart, Lung and Circulation 2010 (Vol. 19Supplement 2, Page S157)

17. Transcatheter Aortic Valve Implantation—Single Centre Outcomes From the First 250 High-Risk Patients. Mini Oral Presentation. R. Gurvitch, E. Tay, F. Nietlispach, N. Wijesinghe, D.Wood, A. Cheung, C. Thompson, J. Ye, S. Lichtenstein, J. Webb. Heart, Lung and Circulation 2010 (Vol. 19Supplement 2, Page S155)

18. Cerebrovascular Events Following Transcatheter Aortic Valve Replacement—Incidence, Predictors and Timing of Events. Mini oral presentation. E. Tay, R. Gurvitch * , N. Wijesinghe, F. Nietlispach, D. Wood, J. Ye, A. Cheung, R. Carere, S. Lichtenstein, C. Thompson, J.Webb. Heart, Lung and Circulation 2010 (Vol. 19Supplement 2, Page S123)

19. Transcatheter Aortic Valve Implantation in Patients with Bicuspid Aortic Valve Stenosis. Poster presentation. N. Wijesinghe, J. Ye, J. Rodes-Cabau, A. Cheung, J. Velianou, M. Natarajan, E. Dumont, F. Nietlispach, R. Gurvitch, D. Wood, E. Tay, J. Webb. Heart, Lung and Circulation 2010 (Vol. 19Supplement 2, Page S156)

20. An Embolic Deflection Device for Aortic Valve Interventions. Poster presentation. F. Nietlispach, N. Wijesinghe, R. Gurvitch, E. Tay, J. Webb. Heart, Lung and Circulation 2010 (Vol. 19Supplement 2, Page S120).

21. Transcatheter Closure of Paravalvular Defects Using a New Purpose- Specific Occluder. Post presentation. F. Nietlispach, M. Johnson, R. Moss, R. Gurvitch, E. Tay, N. Wijesinghe, C. Thompson, J. Webb. Heart, Lung and Circulation 2010 (Vol. 19Supplement 2, Pages S156-S157).

22. A Novel Real-Time Image Processor to Facilitate Transcatheter Aortic Valve Implantation. The Paieon's C-THV System. Post presentation. N. Wijesinghe, J. Masson, F. Nietlispach, E. Tay, R. Gurvitch, D. Wood, J. Webb. Heart, Lung and Circulation 2010 (Vol. 19Supplement 2, Pages S118-S119).

23. American College of Cardiology, Atlanta, GA, March 2010. Long Term Durability of Edwards Transcatheter Balloon Expandable Valve Implantation. Moderated Poster Presentation. Gurvitch R, Wood DA, Tay EL, Leipsic J, Ye J, Lichtenstein SV, Thompson CR, Carere RG, Wijesinghe N, Nietlispach F, Boone RH, Lauck S, Cheung A, Webb JG. J. Am. Coll. Cardiol., March 9, 2010; 55: A151.E1421 (Winning Presentation).

24. Transcatheter Aortic Valve Implantation: single Centre Outcomes from Vancovuer, Canada. Moderated poster presentation. Gurvitch R, Nietlispach F, Cheung A, ye J, Wood DA, Wijesinghe N, Tay EL, Thompson CR, Lichtenstein S, Webb JG. J. Am. Coll. Cardiol., March 9, 2010; 55: A145.E1360.

25. Transcatheter valve in valve implantation for failed bioprosthetic heart valves. Moderated poster presentation. Wood DA, Gurvitch R, Cheung A, Ye J, Leipsic J, Horlick E, Rodes-Cabau J, Dumont E, Osten M, Wender O, Masson JB, Wijesinghe N, Tay E, Nietlispach F, Johnson M, Munt B, Moss R, Thompson C, Lichtenstein S, Webb JG. J. Am. Coll. Cardiol., March 9, 2010; 55: A147.E1385.

26. Paieon’s C-THV System – A Novel Real Time Image Processor to Facilitate Transcatheter Aortic Valve Implantation. Poster presentation. Namal Wijesinghe, Jean-Bernard Masson, Fabian Nietlispach, Edgar Tay, Ronen Gurvitch, Amir Blumenfeld, Rafi Brada, David A. Wood, and John G. Webb J. Am. Coll. Cardiol., March 9, 2010; 55: A147.E1384.

27. Mortality on the Waiting List For Transcatheter Aortic Valve Implantation. A Single Center Experience From Vancouver, Canada. Moderated poster presentation. Edgar Tay, Eve Aymong, Namal Wijesinghe, Fabian Nietlispach, Ronen Gurvitch, David Wood, Ronald Carere, Jian Ye, Anson Cheung, and John Webb, J. Am. Coll. Cardiol., March 9, 2010; 55: A213.E2010.

28. Transcatheter Aortic Valve Implantation (TAVI) in Bicuspid Aortic Stenosis. Moderated poster presentation. Namal Wijesinghe, Fabian Nietlispach, Ronen Gurvitch, Edgar Tay, David A. Wood, Josep Rodés-Cabau, James L. Velianou, Madhu K. Natarajan, Jian Ye, Eric Dumont, Anson Cheung, and John G. Webb, J. Am. Coll. Cardiol., March 9, 2010; 55: A148.E1386.

29. Cardiac Society of Australia and New Zealand, Sydney, August 2009. Zotarolimus eluting stent use in small coronary vessels (≤2.5mm) results in similar 12-month clinical outcomes compared to Sirolimus and Paclitaxel eluting stents. Mini Oral Presentation. R. Gurvitch, W. Wilson, M. Watts, J. Lefkovits, R.J Warren, R. Iyer, A. Brennan, N. Andrianopoulos, C. Reid, A.E Ajani. Heart, Lung and Circulation 2009 (Vol. 18Supplement 3, Page S240).

30. Long-term clinical outcomes of restricting drug-eluting stent use to patients at highest risk of re-stenosis. Mini Oral Presentation. R. Gurvitch, W. Wilson, P. Roy, B.P Yan, A. Bowyer, A.E Ajani, J. Lefkovits, R.J Warren. Heart, Lung and Circulation 2009 (Vol. 18Supplement 3, Pages S218-S219).

View More

Videos

Aortic Stenosis
Diagnosing and Treating Aortic Stenosis
TAVI & the Multidisciplinary Team

Related Articles

LATEST IN Accredited TAVI Practitioner

Mitral Valve Regurgitation (MVR) is the most common valvular abnormality…

LATEST IN Accredited TAVI Practitioner

What is Chest Pain? Chest pain describes a feeling of…

LATEST IN Accredited TAVI Practitioner

As we get closer to the end of the year,…